Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 March 2022 | Story Leonie Bolleurs | Photo Supplied
Dr Edson Vengeai
Dr Edson Vengesai believes accreditation from and affiliation with the CFA Institute signals to potential students, employers, and the marketplace that the UFS BCom Investment Management and Banking curriculum is well-suited to prepare students for a brighter career in the investment field.

The University of the Free State (UFS) Faculty of Economic and Management Sciences was recently welcomed into the world’s largest association of investment professionals, the CFA Institute University Affiliation Programme. The CFA designation is globally recognised as the gold standard in the investment field.

Accreditation by this respected source of knowledge in investment and portfolio management reflects the rigour and value of the UFS BCom Investment Management and Banking (IMB) degree – housed in the more than a century-old Department of Economics and Finance. 

According to Dr Edson Vengesai, Senior Lecturer in the Department of Economics and Finance, the BCom IMB positions students well to obtain the Chartered Financial Analyst (CFA®) charter, which has become the world's most respected and recognised investment credential. Including the UFS, only five universities in South Africa are affiliated to the CFA Institute. 

Most respected investment designation

Members who have attained the prestigious designation ‘Chartered Financial Analyst’, hold prominent roles in leading investment firms in financial centres worldwide. “Becoming a charter holder is a defining moment for many investment professionals, which exemplifies a robust understanding of advanced investment analysis and real-world portfolio management skills,” he says.  

Dr Vengesai states that with this affiliation from the CFA Institute, the BCom IMB degree has been acknowledged as incorporating at least 70% of the CFA Program Candidate Body of Knowledge (CBOK) within the programme. Moreover, it also places emphasis on the CFA Institute Code of Ethics and Standards of Professional Conduct. He believes preparing graduates who are ethically grounded and ready to execute their duties in an ethical and professional manner is a major necessity in the financial analysis and investment field.

Writing from London in the United Kingdom, Director of University Relations at the CFA Institute, Peter Watkins, states: “The UFS BCom in Investment Management and Banking is a rigorous programme that will be of great benefit to students entering the investment profession.”

Dean of the Faculty of Economic and Management Sciences and Pro-Vice-Chancellor: Poverty, Inequality and Economic Development, Prof Philippe Burger, adds that the accreditation aligns with the faculty’s drive to create opportunities for its students to not only pursue excellence, but also to compare with the best in the industry, locally and on an international basis. He says the BCom in Investment Management and Banking is one of a range of cutting-edge, industry-relevant, and scientifically rigorous degrees offered by the Faculty of Economic and Management Sciences. “Quite a number of the faculty’s programmes are accredited by professional bodies, with accreditation by the CFA being the latest.”

Taking the financial sector to new heights

Through the CFA programme, the UFS will also be eligible to receive CFA Programme Student Scholarships each year, which will contribute to the much-needed skill set of well-grounded financial analysts who can take the financial sector to new heights. “Aligning our degree programme with the CFA curriculum will equip our students with the kind of expertise and real-world skills in investment analysis that will help set them apart from other institutions and peers,” adds Dr Vengesai, who also aims to produce a breed of innovators, critical thinkers, and producers of information.

“The affiliation signals to potential students, employers, and the marketplace that the UFS BCom Investment Management and Banking curriculum is closely tied to professional practices and is well-suited to prepare students for a brighter career in the investment field,” Dr Vengesai concludes. 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept